华熙生物跌4.16% 西部证券喊买入后屡跌

Group 1 - The core viewpoint of the article indicates that Huaxi Biological (688363.SH) has experienced a stock price decline of 4.16%, closing at 43.32 yuan [1] - The research report by Western Securities analysts Wu Cen and Yu Jiaqi, published on December 3, maintains a "buy" rating for Huaxi Biological despite the recent stock price drop [1] - The report highlights that the main business of Huaxi Biological is under pressure, but structural optimization and the establishment of a technology platform are expected to initiate new growth [1]